for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Konica Minolta Inc

4902.T

Latest Trade

744.00JPY

Change

24.00(+3.33%)

Volume

3,949,000

Today's Range

728.00

 - 

744.00

52 Week Range

705.00

 - 

1,149.00

As of on the Tokyo Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
720.00
Open
730.00
Volume
3,949,000
3M AVG Volume
57.26
Today's High
744.00
Today's Low
728.00
52 Week High
1,149.00
52 Week Low
705.00
Shares Out (MIL)
494.82
Market Cap (MIL)
361,918.30
Forward P/E
12.73
Dividend (Yield %)
4.17

Next Event

Q3 2020 Konica Minolta Inc Earnings Release

Latest Developments

More

Konica Minolta Healthcare Americas' Dynamic Digital Radiography Receives FDA Clearance

Konica Minolta Expands Enterprise Content Management Portfolio With Acquisition Of Vebridge Holdings, Inc.

R&I affirms Konica Minolta's rating at "A" and says stable outlook-R&I

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Konica Minolta Inc

KONICA MINOLTA, INC. is a Japan-based company mainly engaged in office business and other businesses. The Company operates four business segments. The Office segment develops, manufactures and sells multifunction machines and related consumables, and provides related solution services. The Professional Print segment develops, manufactures and sells digital printing systems and related consumables, and provides various printing services, solutions and services. The Healthcare segment provides imaging diagnostic systems (digital x-ray diagnostic imaging, ultrasound diagnostic imaging systems, etc.), and medical digitization, networking, solution services. The Industrial Materials and Equipment segment includes the fields of materials and components, the field of industrial optical systems.

Industry

Office Equipment

Contact Info

14F/15F, JP Tower, 2-7-2, Marunouchi

+81.3.62502111

https://www.konicaminolta.com/jp-ja/

Executive Leadership

Masatoshi Matsuzaki

Chairman of the Board of Directors, Director

Shoei Yamana

President, Chief Executive Officer, Representative Executive Officer, Director

Kiyotaka Fujii

Senior Managing Executive Officer, Chief Director of Healthcare Business, Chairman of Subsidiary

Seiji Hatano

Managing Executive Officer, Director

Kunihiro Koshizuka

Managing Executive Officer, Director

Key Stats

2.87 mean rating - 15 analysts
Sell
Hold
Buy
Revenue (MM, JPY)

2017

1.0K

2018

1.0K

2019

1.1K

2020(E)

1.1K
EPS (JPY)

2017

63.650

2018

65.170

2019

84.330

2020(E)

56.557
Price To Earnings (TTM)
19.35
Price To Sales (TTM)
0.35
Price To Book (MRQ)
0.68
Price To Cash Flow (TTM)
4.19
Total Debt To Equity (MRQ)
72.74
LT Debt To Equity (MRQ)
63.18
Return on Investment (TTM)
1.89
Return on Equity (TTM)
1.46

Latest News

Latest News

BRIEF-Konica Minolta's Sales For Year Ending March 2019 Will Likely Rise 9 Percent - Nikkei

* KONICA MINOLTA'S OPERATING PROFIT IS EXPECTED TO CLIMB ABOUT 20 PERCENT TO A LITTLE OVER 60 BILLION YEN THIS FISCAL YEAR - NIKKEI

BRIEF-Clavister Holding AB Enters Cooperation With Konica Minolta Sverige

* ENTERS COOPERATION WITH KONICA MINOLTA SVERIGE Source text for Eikon: Further company coverage:

BRIEF-Mobotix: Konica Minolta Invests EUR 1.5 Mln In Technology Development Of Mobotix

* KONICA MINOLTA IS INITIALLY INVESTING 1.5 MILLION EUROS IN THE TECHNOLOGY DEVELOPMENT OF MOBOTIX Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF- Konica Minolta unit and INCJ buy Ambry Genetics

* Says its U.S.-based unit Konica Minolta Healthcare Americas, Inc. and Innovation Network Corporation of Japan (INCJ)jointly bought U.S.-based company Ambry Genetics Corporation

EU mergers and takeovers (Oct 6)

The following are mergers under review by the European Commission and a brief guide to the EU merger process:

BRIEF-R&I affirms Konica Minolta's rating at "A" and says stable outlook-R&I

* Says Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "A" -R&I

Konica Minolta to buy Ambry Genetics, deal worth up to $1 billion

Konica Minolta Inc <4902.T> said it was purchasing U.S. diagnostics company Ambry Genetics in a deal valued at up to $1 billion - an acquisition that marks a strategic shift for the Japanese firm's healthcare business as it seeks a leading position in precision medicine.

Konica Minolta to buy Ambry Genetics, deal worth up to $1 bln

Japan's Konica Minolta said on Thursday it was purchasing U.S.-based testing company Ambry Genetics in a deal valued at up to $1 billion.

BRIEF-Konica Minolta to buy Ambry Genetics for $1 bln

* Konica Minolta to acquire U.S.-based Ambry Genetics in a deal valued at US$1 billion

BRIEF-Konica Minolta's U.S.-based unit and Innovation Network Corporation of Japan to acquire Ambry Genetics Corporation for 90.2 bln yen

* Says its U.S.-based unit Konica Minolta Healthcare Americas, Inc. and Innovation Network Corporation of Japan will jointly acquire all shares of Ambry Genetics Corporation, for 90.2 billion yen, from Charles L.M. Dunlop, effective October

Japan's Konica Minolta plans to buy U.S. cancer test firm: Nikkei

Japanese office equipment maker Konica Minolta Inc <4902.T> plans to acquire U.S. healthcare firm Ambry Genetics Corp to diversify its business, the Nikkei daily reported on Sunday.

Japan's Konica Minolta plans to buy U.S. cancer test firm -Nikkei

Japanese office equipment maker Konica Minolta Inc plans to acquire U.S. healthcare firm Ambry Genetics Corp to diversify its business, the Nikkei daily reported on Sunday.

BRIEF-Konica Minolta and Pioneer set to merge OLED lighting ops - Nikkei

* Konica Minolta and Pioneer are concluding talks to merge their OLED lighting businesses under a 50-50 joint venture - Nikkei

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up